Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Biomarin Pharmaceutical Inc Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$83.4 Billion
Q1 2025

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 50,291 shares of BMRN stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,291

Previous 36,797 36.67%

Holding current value

$2.77 Million

Previous $2.42 Million 47.02%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$61.25 - $72.83 $826,507 - $982,768	13,494 Added 36.67%	50,291 $3.56 Million
Q4 2024 Feb 14, 2025	SELL	$61.93 - $70.49 $1.28 Million - $1.46 Million	-20,689 Reduced 35.99%	36,797 $2.42 Million
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $2.89 Million - $3.93 Million	41,845 Added 267.53%	57,486 $4.04 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $9.03 Million - $11.2 Million	-121,348 Reduced 88.58%	15,641 $1.29 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $588,597 - $695,277	7,023 Added 5.4%	136,989 $12 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $1.63 Million - $2.11 Million	-21,421 Reduced 14.15%	129,966 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $4.76 Million - $5.29 Million	56,011 Added 58.73%	151,387 $13.4 Million
Q2 2023 May 17, 2024	SELL	$86.68 - $100.3 $3.61 Million - $4.17 Million	-41,613 Reduced 30.38%	95,376 $8.27 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $3.24 Million - $3.75 Million	-37,398 Reduced 28.17%	95,376 $8.27 Million
Q1 2023 May 17, 2024	SELL	$87.74 - $117.27 $6.61 Million - $8.83 Million	-75,292 Reduced 36.19%	132,774 $12.9 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $6.61 Million - $8.83 Million	-75,292 Reduced 36.19%	132,774 $12.9 Million
Q4 2022 May 17, 2024	BUY	$80.93 - $108.63 $5.75 Million - $7.72 Million	71,077 Added 51.89%	208,066 $21.5 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $1.16 Million - $1.55 Million	14,281 Added 7.37%	208,066 $21.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3.35 Million - $3.96 Million	40,806 Added 26.67%	193,785 $16.4 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $2.02 Million - $2.46 Million	28,323 Added 22.72%	152,979 $12.7 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $513,571 - $640,858	6,914 Added 5.87%	124,656 $9.61 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $212,936 - $271,574	-2,969 Reduced 2.46%	117,742 $10.5 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $995,861 - $1.14 Million	13,319 Added 12.4%	120,711 $9.33 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $3.21 Million - $3.61 Million	42,538 Added 65.59%	107,392 $8.96 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $1.8 Million - $2.24 Million	24,854 Added 62.14%	64,854 $5.65 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $842,000 - $986,200	10,000 Added 33.33%	40,000 $3.55 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $5.72 Million - $7.45 Million	-75,200 Reduced 71.48%	30,000 $2.83 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $5.84 Million - $6.97 Million	75,200 Added 250.67%	105,200 $8.53 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $2.42 Million - $2.85 Million	30,000	30,000 $2.68 Million

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

184M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Biomarin Pharmaceutical Inc Transaction History